| Stage | FLXS | % of rev | RCKY | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $98M | 100.00% | $139M | 100.00% | RCKY ×1.41 |
| Gross profit | $20M | 20.16% | $62M | 45.02% | RCKY +24.9pp |
| Operating income | $14M | 13.91% | $18M | 13.09% | FLXS +0.8pp |
| Pre-tax income | $13M | 13.41% | $16M | 11.79% | FLXS +1.6pp |
| Net income | $10M | 10.09% | $13M | 9.26% | FLXS +0.8pp |
| Stage | FLXS | RCKY | Gap · A − B |
|---|---|---|---|
| Revenue | $98M100.00% | $139M100.00% | RCKY ×1.41 |
| Gross profit | 20.16%$20M | 45.02%$62M | RCKY +24.9pp |
| Operating income | 13.91%$14M | 13.09%$18M | FLXS +0.8pp |
| Pre-tax income | 13.41%$13M | 11.79%$16M | FLXS +1.6pp |
| Net income |
| 10.09%$10M |
| 9.26%$13M |
| FLXS +0.8pp |
None
No disclosed counterparties: FLXS.